Showing results (2281-2290 of 2,613) with videos related to
Sort By:
Pageof 262
Open Forum Infectious Diseases|January 15, 2024
Reducing Initial Loss to Follow-up Among People With Bacteriologically Confirmed Tuberculosis: LINKEDin, a Quasi-experimental Study in South AfricaSue-Ann Meehan, Anneke C Hesseling, Andrew Boulle, et al.Expert Review of Clinical Immunology|December 23, 2015
Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendationsPilar Brito-Zerón, Elke Theander, Chiara Baldini, et al.Frontiers in Plant Science|June 11, 2021
Consequences of Mixotrophy on Cell Energetic Metabolism in Microchloropsis gaditana Revealed by Genetic Engineering and Metabolic ApproachesDavide Dal Bo, Leonardo Magneschi, Mariette Bedhomme, et al.Annals of the Rheumatic Diseases|May 30, 2014
Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA)Maxime Dougados, Martin Soubrier, Elodie Perrodeau, et al.The Lancet. Rheumatology|March 4, 2024
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohortsYann Nguyen, Gaëtane Nocturne, Julien Henry, et al.Plos One|August 29, 2022
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 miceKatherine S Lee, Ting Y Wong, Brynnan P Russ, et al.Infection and Immunity|July 18, 2018
Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in MiceDylan T Boehm, Jesse M Hall, Ting Y Wong, et al.JAMA|July 17, 2014
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trialJacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, et al.RMD Open|March 4, 2025
Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmesXavier Mariette, Sven Borchmann, Sandrine Aspeslagh, et al.Infection and Immunity|July 18, 2024
Virus-like particles displaying the mature C-terminal domain of filamentous hemagglutinin are immunogenic and protective against Bordetella pertussis respiratory infection in miceGage M Pyles, Annalisa B Huckaby, Maria de la Paz Gutierrez, et al.Pageof 262